Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVANCE-PD: IPX066 in Advanced Parkinson's Disease
NCT00974974Phase 3Completed
- Sponsor
- Impax Laboratories
- Start
- Sep 2009
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of carbidopa + levodopa in Parkinson's disease (PD), sponsored by Impax Laboratories. Started Sep 2009; status: completed.
02
Drugs
carbidopa + levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00974974.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00974974.